Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
pasquale.pignatelli@uniroma1.it
Pasquale Pignatelli
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
pasquale.pignatelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
DATA IN BRIEF
2018
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
INTERNAL AND EMERGENCY MEDICINE
2018
Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events
ATHEROSCLEROSIS
2018
Digoxin and platelet activation in patients with atrial fibrillation: In vivo and in vitro study
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2018
Integrated care management of patients with atrial fibrillation and risk of cardiovascular events. the abc (atrial fibrillation better care) pathway in the ATHERO-AF study cohort
MAYO CLINIC PROCEEDINGS
2018
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
INTERNATIONAL JOURNAL OF CARDIOLOGY
2018
Oxidative stress and cardiovascular disease: New insights
KARDIOLOGIA POLSKA
2018
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2018
Impact of tobacco versus electronic cigarette smoking on platelet function
THE AMERICAN JOURNAL OF CARDIOLOGY
2018
Sex and gender differences in ischemic heart disease. Endocrine vascular disease approach (eva) study design
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
2018
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation
AMERICAN HEART JOURNAL
2018
Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. results from the observational retrospective multicentre PLECTRUM study
OPEN HEART
2018
Comparison of the 2MACE and TIMI-AF scores for composite clinical outcomes in anticoagulated atrial fibrillation patients
CIRCULATION JOURNAL
2018
Epidemiology and management of patients with acute coronary syndromes in contemporary real-world practice. evolving trends from the EYESHOT study to the START-ANTIPLATELET registry
ANGIOLOGY
2018
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
INTERNAL AND EMERGENCY MEDICINE
2018
NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous Disease.
ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY
2017
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal medicine wards. a multicenter study
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2017
Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production
THROMBOSIS AND HAEMOSTASIS
2017
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2017
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2017
« first
< previous
…
2
3
4
5
6
7
8
9
10
11
12
13
next >
last »
ERC
LS1_2
LS1_5
LS2_16
LS3
LS4
LS4_3
LS4_7
LS4_10
LS8_4
Keywords
Modulation of Oxidative Stress
Platelets
Atherothrombosis
Thrombosis
Progetti di Ricerca
The role of gut permeability in patients with cardiovascular disease
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9), PLATELET ACTIVATION AND RISK OF CARDIOVASCULAR EVENTS IN ATRIAL FIBRILLATION
PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation.
PCSK9 e attivazione piastrinica: implicazioni nei pazienti con fibrillazione atriale
Gruppi di ricerca
Cardiologia geriatrica
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma